asthma

Asthma is a chronic airway inflammatory disease affecting over 260 million people globally, ranging from mild intermittent to severe therapy-refractory disease. Inhaled corticosteroids remain the cornerstone of maintenance therapy, while add-on biologics targeting IL-4, IL-5, IL-13, and TSLP have transformed severe asthma management. Phenotyping and treatable traits approaches are guiding more precise therapeutic selection.